Search results
FDA misses own deadline to propose ban on cancer-linked formaldehyde from hair relaxers
TODAY via Yahoo News· 12 hours agoThe FDA announced it would propose a ban on formaldehyde commonly found in hair relaxers typically...
Geron Corp (GERN) Q1 2024 Earnings Call Transcript Highlights: S
Guru Focus· 17 minutes agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. FDA's Oncology Drug Advisory Committee voted favorably on imetelstat's ...
FDA, doctors warn about compounded Ozempic. What we found at metro weight loss clinics
WFXT via Yahoo News· 1 day agoIt’s a popular drug that millions of people are taking to lose weight, but the federal government...
FDA Finalizes LDT Regulation, with Significant Exceptions: Enforcement of Requirements Will Phase In...
JD Supra· 13 hours agoOn April 29, 2024, the Office of the Federal Register placed on display the Food and Drug Administration’s (FDA) final rule on the regulation of laboratory developed tests ...
Apple Watch feature becomes first digital health tech to receive this FDA approval
Mashable· 12 hours agoThe FDA just gave the Apple Watch a historic first approval for a digital health tech device....
FDA has completed its testing for bird flu in milk, dairy products — and more
WGN Chicago via Yahoo News· 10 hours agoFor Thursday, May 2, WGN’s Ben Bradley and Lourdes Duarte have the latest on new medical...
Are milk and ground beef safe from bird flu? What the latest testing tells us.
Yahoo Life Style via AOL· 8 hours agoFDA testing detected the genetic material of avian flu in about 20% of samples of grocery store...
FDA Issues Final Rule on Laboratory-Developed Tests | JD Supra
JD Supra· 1 day agoOn April 29, 2023, the FDA announced a final rule on regulation of laboratory developed tests (LDTs). The rule explicitly categorizes in vitro...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 41 minutes agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi's sBLA for Dupixent for COPD treatment was accepted by the FDA for priority review, highlighting progress in expanding ...
Oops They Did It Again: FDA Misses Deadline To Propose A Ban On Formaldehyde, The Chemical Often...
Essence· 12 hours agoThe U.S. Food and Drug Administration (FDA) failed to meet their own deadline in April to issue a...